Physician

Ira Younger, M.D.

According to 2025 Medicare claims, Ira Younger, M.D. (NPI: 1194898692) practices ophthalmology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Dearborn, IN. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP, INC (NPI: 1750343216; TIN: 611300608) and primary practice location at 47025-1095. Younger is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Younger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,197 traditional Medicare patients, billed 3,183 HCPCS/CPT codes, and received $238,124 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,259 prescription claims across 528 beneficiaries totaling $258,494 in drug costs, led by Lumigan (Bimatoprost). DME data shows 11 claims. Open Payments data shows 1 records totaling $20. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $379,164 to $238,124. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,412	4,648	$379,164
2016	1,489	4,618	$371,882
2017	1,556	4,941	$373,959
2018	1,485	4,578	$352,781
2019	1,541	4,679	$355,079
2020	1,176	3,527	$280,912
2021	1,174	3,262	$273,534
2022	1,264	3,292	$247,821
2023	1,256	3,337	$258,736
2024	1,197	3,183	$238,124

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	415	1,720	$218,976
2016	400	1,796	$255,289
2017	387	1,742	$248,612
2018	433	1,995	$299,074
2019	446	1,881	$278,856
2020	438	1,902	$284,206
2021	430	1,750	$265,358
2022	461	1,854	$230,624
2023	533	2,060	$239,847
2024	528	2,259	$258,494

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	26	26	$1,191
2016	29	29	$1,403
2017	13	13	$616
2018	N/R	N/R	N/R
2019	13	13	$648
2020	15	15	$785
2021	29	29	$1,525
2022	11	11	$593
2023	12	12	$695
2024	11	11	$637

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	201	201	$93
92014	Established patient complete exam of visual system	953	1,149	$77
92012	Established patient problem focused exam of visual system	279	449	$59
92083	Exam of visual field with extended testing	367	376	$41
92133	Imaging of optic nerve	377	485	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	205	12,441	$111,570
Rhopressa	Netarsudil Mesylate	64	2,441	$27,023
Restasis	Cyclosporine	20	990	$19,735
Rocklatan	Netarsudil Mesylat/Latanoprost	17	1,045	$13,680
Combigan	Brimonidine Tartrate/Timolol	27	1,215	$9,279

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2020	Frames, purchases	N	11	11	$637

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$20	Tarsus Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ira Younger, M.D.?

Tedicare shows public-source Medicare data for Ira Younger, M.D. (NPI 1194898692), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ira Younger, M.D. have ACO affiliation data?

Ira Younger, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Ira Younger, M.D.?

Ira Younger, M.D. is linked to SUMMIT MEDICAL GROUP, INC (billing NPI 1750343216) in the available physician profile data.

Does Ira Younger, M.D. have Open Payments data?

Ira Younger, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.